Access
This article is part of Nature's premium content.
Published online 18 September 2003 | Nature | doi:10.1038/news030915-6
News
Drug companies snub antibiotics
Pipeline threatens to run dry as pharma concentrate on chronic illness.
This story is from the news section of the journal Nature
Major drug companies are pulling out of antibiotic development - and their timing couldn't be worse, a leading meeting on infectious disease was told this week.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.